Proinflammatory cytokines are involved in the initiation of the abnormal matrix process in pseudoexfoliation syndrome/glaucoma.

Pseudoexfoliation (PEX) syndrome, which is an age-related, generalized elastotic matrix process, currently represents the most common identifiable risk factor for open-angle glaucoma. Dysregulated expression of proinflammatory cytokines has been implicated in the initiation of various fibrotic disorders and in the pathophysiology of glaucoma. Here we investigated the presence, expression, regulation, and functional significance of proinflammatory cytokines in eyes with early and late stages of PEX syndrome/glaucoma in comparison with normal and glaucomatous control eyes using multiplex bead analysis, immunoassays, real-time PCR, Western blotting, immunohistochemistry, and cell culture models. Early stages of PEX syndrome were characterized by approximately threefold (P < 0.005) elevated interleukin (IL)-6 and IL-8 levels in the aqueous humor and a concomitant approximately twofold (P < 0.001) increase in mRNA expression levels in anterior segment tissues as compared with controls. In contrast, late stages of PEX syndrome/glaucoma did not differ significantly from controls. IL-6, IL-6 receptor, and phospho-signal transducer and activator of transcription 3 could be mainly localized to walls of iris vessels and to the nonpigmented epithelium of ciliary processes. IL-6 and IL-8 were significantly up-regulated by ciliary epithelial cells in response to hypoxia or oxidative stress in vitro, whereas IL-6, but not IL-8, induced the expression of transforming growth factor-beta1 and elastic fiber proteins. These findings support a role for a stress-induced, spatially, and temporally restricted subclinical inflammation in the onset of the fibrotic matrix process characteristic of PEX syndrome/glaucoma.

[1]  R. Ritch.  Exfoliation syndrome. , 2018, Current opinion in ophthalmology.

[2]  R. Gallucci,et al.  Interleukin (IL)‐6 modulates transforming growth factor‐β expression in skin and dermal fibroblasts from IL‐6‐deficient mice , 2009, The British journal of dermatology.

[3]  U. Schlötzer-Schrehardt,et al.  Exploring functional candidate genes for genetic association in german patients with pseudoexfoliation syndrome and pseudoexfoliation glaucoma. , 2009, Investigative ophthalmology & visual science.

[4]  S. S. Zhang,et al.  The two sides of cytokine signaling and glaucomatous optic neuropathy , 2009, Journal of ocular biology, diseases, and informatics.

[5]  D. Epstein,et al.  Cross-talk between TGF-β1 and IL-6 in human trabecular meshwork cells , 2009, Molecular vision.

[6]  D. Epstein,et al.  Cross-talk between TGF-beta1 and IL-6 in human trabecular meshwork cells. , 2009 .

[7]  G. Naumann,et al.  Genotype-correlated expression of lysyl oxidase-like 1 in ocular tissues of patients with pseudoexfoliation syndrome/glaucoma and normal patients. , 2008, The American journal of pathology.

[8]  P. Liton,et al.  Stress Response of the Trabecular Meshwork , 2008, Journal of glaucoma.

[9]  D. Epstein,et al.  Sustained stress response after oxidative stress in trabecular meshwork cells , 2007, Molecular vision.

[10]  G. Naumann,et al.  Impaired cytoprotective mechanisms in eyes with pseudoexfoliation syndrome/glaucoma. , 2007, Investigative ophthalmology & visual science.

[11]  Kari Stefansson,et al.  Common Sequence Variants in the LOXL1 Gene Confer Susceptibility to Exfoliation Glaucoma , 2007, Science.

[12]  R. Scott,et al.  Multiplex bead analysis of vitreous humor of patients with vitreoretinal disorders. , 2007, Investigative ophthalmology & visual science.

[13]  Stefani N. Thomas,et al.  Proteomic analysis of exfoliation deposits. , 2007, Investigative ophthalmology & visual science.

[14]  N. Suzuki,et al.  Effects of IL-6 and Soluble IL-6 Receptor on the Expression of Cartilage Matrix Proteins in Human Chondrocytes , 2007, Connective tissue research.

[15]  N. Nieto.  Oxidative‐stress and IL‐6 mediate the fibrogenic effects of rodent Kupffer cells on stellate cells , 2006, Hepatology.

[16]  A. Rothova,et al.  Distinct cytokine and chemokine profiles in the aqueous of patients with uveitis and cystoid macular edema. , 2006, American journal of ophthalmology.

[17]  L. Ferrucci,et al.  Interleukin-6 in aging and chronic disease: a magnificent pathway. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.

[18]  H. Chung,et al.  The molecular inflammatory process in aging. , 2006, Antioxidants & redox signaling.

[19]  G. Naumann,et al.  Ocular and systemic pseudoexfoliation syndrome. , 2006, American journal of ophthalmology.

[20]  G. Naumann,et al.  Clusterin deficiency in eyes with pseudoexfoliation syndrome may be implicated in the aggregation and deposition of pseudoexfoliative material. , 2006, Investigative ophthalmology & visual science.

[21]  D. Epstein,et al.  Induction of IL-6 expression by mechanical stress in the trabecular meshwork. , 2005, Biochemical and biophysical research communications.

[22]  F. Falciani,et al.  Multiplex bead immunoassay analysis of aqueous humor reveals distinct cytokine profiles in uveitis. , 2005, Investigative ophthalmology & visual science.

[23]  J. Herruzo,et al.  IL-6 and extracellular matrix remodeling. , 2005 .

[24]  M. Salmon,et al.  The role of chemokines and their receptors in ocular disease , 2004, Progress in Retinal and Eye Research.

[25]  R. Ritch,et al.  8-Isoprostaglandin F2a and ascorbic acid concentration in the aqueous humour of patients with exfoliation syndrome , 2003, The British journal of ophthalmology.

[26]  U. Schlötzer-Schrehardt,et al.  Expression and localization of FP and EP prostanoid receptor subtypes in human ocular tissues. , 2002, Investigative ophthalmology & visual science.

[27]  U. Schlötzer-Schrehardt,et al.  Role of transforming growth factor-beta1 and its latent form binding protein in pseudoexfoliation syndrome. , 2001, Experimental eye research.

[28]  P. Sime,et al.  A new direction in the pathogenesis of idiopathic pulmonary fibrosis? , 2001, Respiratory research.

[29]  U. Schlötzer-Schrehardt,et al.  Unilateral or asymmetric pseudoexfoliation syndrome? An ultrastructural study. , 2001, Archives of ophthalmology.

[30]  D. Sheppard.  Pulmonary fibrosis: a cellular overreaction or a failure of communication? , 2001, The Journal of clinical investigation.

[31]  D. Anthony,et al.  Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. , 2001, The Journal of clinical investigation.

[32]  J. Schuman,et al.  Activation of a tissue-specific stress response in the aqueous outflow pathway of the eye defines the glaucoma disease phenotype , 2001, Nature Medicine.

[33]  T. Crombleholme,et al.  Diminished interleukin 6 (IL-6) production during scarless human fetal wound repair. , 2000, Cytokine.

[34]  D. Epstein,et al.  Genes upregulated in the human trabecular meshwork in response to elevated intraocular pressure. , 2000, Investigative ophthalmology & visual science.

[35]  Jorn-Hon Liu,et al.  Increased interleukin-6 in aqueous humor of neovascular glaucoma. , 1999, Investigative ophthalmology & visual science.

[36]  O. Eickelberg,et al.  Hypoxia-induced interleukin-6 and interleukin-8 production is mediated by platelet-activating factor and platelet-derived growth factor in primary human lung cells. , 1998, American journal of respiratory cell and molecular biology.

[37]  M. Fujimoto,et al.  Serum levels of interleukin 6 (IL-6), oncostatin M, soluble IL-6 receptor, and soluble gp130 in patients with systemic sclerosis. , 1998, The Journal of rheumatology.

[38]  J. Darbon,et al.  Interleukin‐6 in Tear Fluid After Photorefractive Keratectomy and Its Effects on Keratocytes in Culture , 1997, Cornea.

[39]  U. Schlötzer-Schrehardt,et al.  Anterior-chamber hypoxia and iris vasculopathy in pseudoexfoliation syndrome. , 1994, German journal of ophthalmology.

[40]  L. Mucke,et al.  Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[41]  T. Whiteside,et al.  Cytokine production and serum levels in systemic sclerosis. , 1992, Clinical immunology and immunopathology.

[42]  I. Morita,et al.  IL-6 increases endothelial permeability in vitro. , 1992, Endocrinology.

[43]  B. Berman,et al.  Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6. , 1991, The Journal of investigative dermatology.

[44]  P. Martín-Vasallo,et al.  Expression of Na,K‐ATPase alpha subunit isoforms in the human ciliary body and cultured ciliary epithelial cells , 1989, Journal of cellular physiology.

[45]  R. Ritch,et al.  Preclinical diagnosis of pseudoexfoliation syndrome. , 1987, Archives of ophthalmology.

[46]  P. de la Torre,et al.  IL-6 and extracellular matrix remodeling. , 2005, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

[47]  Jeung-Hoon Lee,et al.  Sphingosylphosphorylcholine stimulates cellular fibronectin expression through upregulation of IL-6 in cultured human dermal fibroblasts , 2002, Archives of Dermatological Research.

[48]  N. Nguyen,et al.  The blood-aqueous barrier in eyes with pseudoexfoliation syndrome. , 1995, Ophthalmic research.

[49]  T. Hirano,et al.  Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily , 1994, Stem cells.